Vanguard Group Inc. Has $3.25 Billion Stake in Humana Inc. (NYSE:HUM)

Vanguard Group Inc. grew its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 15.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 12,829,210 shares of the insurance provider's stock after purchasing an additional 1,751,857 shares during the quarter. Vanguard Group Inc. owned 10.65% of Humana worth $3,254,899,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Pzena Investment Management LLC grew its holdings in Humana by 44.0% during the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock worth $915,736,000 after acquiring an additional 1,103,132 shares during the period. Boston Partners boosted its position in shares of Humana by 435.8% during the 4th quarter. Boston Partners now owns 1,098,702 shares of the insurance provider's stock valued at $279,236,000 after purchasing an additional 893,637 shares in the last quarter. FMR LLC grew its stake in shares of Humana by 23.4% in the 3rd quarter. FMR LLC now owns 3,388,859 shares of the insurance provider's stock worth $1,073,387,000 after purchasing an additional 643,291 shares during the last quarter. Retirement Systems of Alabama raised its holdings in shares of Humana by 735.9% in the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock worth $55,563,000 after purchasing an additional 192,801 shares in the last quarter. Finally, Worldquant Millennium Advisors LLC acquired a new stake in Humana during the third quarter valued at approximately $50,102,000. Institutional investors own 92.38% of the company's stock.

Remove Ads

Insiders Place Their Bets

In related news, insider Timothy S. Huval sold 3,703 shares of the firm's stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the transaction, the insider now directly owns 8,181 shares of the company's stock, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.37% of the company's stock.

Analysts Set New Price Targets

Several brokerages have recently commented on HUM. JPMorgan Chase & Co. reduced their target price on Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a report on Tuesday, February 18th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $283.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Cantor Fitzgerald reissued a "neutral" rating and issued a $290.00 target price on shares of Humana in a research report on Wednesday, February 12th. Truist Financial upped their price target on shares of Humana from $260.00 to $290.00 and gave the company a "hold" rating in a research report on Monday, January 6th. Finally, Morgan Stanley lowered their price objective on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a research report on Wednesday, February 12th. Eighteen investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, Humana currently has a consensus rating of "Hold" and a consensus price target of $285.68.

Humana Stock Performance

Shares of NYSE:HUM traded down $6.43 during trading on Friday, reaching $263.95. The stock had a trading volume of 967,907 shares, compared to its average volume of 1,758,856. The stock has a fifty day simple moving average of $270.14 and a two-hundred day simple moving average of $273.87. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46. The firm has a market capitalization of $31.86 billion, a price-to-earnings ratio of 26.53, a P/E/G ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.34%. Humana's dividend payout ratio (DPR) is 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.